Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Building a better malaria vaccine

Transmission electron micrograph of merozoite-stage malarial parasites, which have caused a red blood cell to rupture. Credit: DENNIS KUNKEL MICROSCOPY/SPL

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 575, S51-S54 (2019)


This article is part of Nature Outlook: Vaccines, an editorially independent supplement produced with the financial support of third parties. About this content.


  1. RTS,S Clinical Trials Partnership Lancet 386, 31–45 (2015).

    Article  Google Scholar 

  2. Venkatraman, N. et al. Preprint at medRxiv (2019).

  3. Ogwang, C. et al. Sci. Transl. Med. 7, 286re5 (2015).

    Article  Google Scholar 

  4. Seder, R. A. Science 341, 1359–1365 (2013).

    Article  Google Scholar 

  5. Mordmüller, B. Nature 542, 445–449 (2017).

    Article  Google Scholar 

  6. Cohen, S, McGregor, I. A. & Carrington, S. Nature 192, 733–737 (1961).

    Article  Google Scholar 

  7. Stanisic, D. I. et al. BMC Med. 16, 184 (2018).

    Article  Google Scholar 

  8. Sagara, I. et al. Lancet Infect. Dis. 18, 969–982 (2018).

    Article  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links